Protocol for Women at Increased Risk of Developing Breast Cancer

Completed · Phase 2 · Has a placebo group

Conditions studied: Breast Cancer

In brief

To assess the effects of twelve months of celecoxib administration by evaluating breast tissue needle aspirations, to determine if cell growth can be slowed.

Key facts

Study ID

NCT00291694

Run by

Carol Fabian, MD

People needed

72

Starts

2003-04-01

Expected to finish

2009-12-01

Last updated by the study team

2016-11-07

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• women who have a high risk of breast cancer
• older than 18 years

You may not qualify if…

• anticoagulants
• marked breast tenderness
• pregnant or within twelve months of breast feeding/childbirth

Where it is running

• University of Kansas Medical Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.